Antithrombotic therapy after prosthetic cardiac valve implantation: improving postoperative, long-term patient management. Introduction.
Berkowitz
S D
SD
Divisions of Hematology and Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. scott.berkowitz@astrazeneca.com
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006351:Heart Valves / Q000601:surgery*; D006801:Humans; D011182:Postoperative Care / Q000379:methods*; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D005343:Fibrinolytic Agents